Literature DB >> 18383041

Defective positive selection results in T cell lymphopenia and increased autoimmune diabetes in ADAP-deficient BDC2.5-C57BL/6 mice.

Liangxing Zou1, Felipe Mendez, Natalia Martin-Orozco, Erik J Peterson.   

Abstract

Adhesion and degranulation promoting adapter protein (ADAP), a positive regulator of T cell receptor (TCR) signaling, is required for thymocyte development and T cell homeostasis. To investigate the role of ADAP in a T cell-driven autoimmune response, we generated ADAP-deficient, BDC2.5 TCR transgenic, diabetes-prone (C57BL/6) mice (BDC/B6). We observed a striking enhancement of diabetes incidence in ADAP-deficient mice, both in animals homozygous for I-Ag7, and in mice carrying one I-Ab allele (BDC/B6g7/b). Increased disease correlates with significantly reduced numbers of pathological CD4(+) T cells in the mice. Consistent with a state of functional lymphopenia in ADAP-deficient BDC/B6g7/b mice, T cells display increased homeostatic proliferation. Transfer of syngeneic lymphocytes or T cells both blocks ADAP-dependent diabetes and relieves exaggerated homeostatic T cell proliferation observed in ADAP-deficient mice. Marked attenuation in cellularity of the CD4+ single-positive thymocyte compartment in ADAP-deficient BDC/B6g7/b animals suggests a mechanism for induction of the lymphopenia. We conclude that inefficient positive selection in ADAP deficiency results in lymphopenia that leads to enhanced autoimmune diabetes in the BDC/B6g7/b model. Our findings support the notion that ineffective thymic T cell output can be a powerful causative factor in lymphopenia-driven autoimmune diabetes.

Entities:  

Mesh:

Substances:

Year:  2008        PMID: 18383041      PMCID: PMC2829296          DOI: 10.1002/eji.200737881

Source DB:  PubMed          Journal:  Eur J Immunol        ISSN: 0014-2980            Impact factor:   5.532


  32 in total

1.  CD25+ CD4+ T cells regulate the expansion of peripheral CD4 T cells through the production of IL-10.

Authors:  O Annacker; R Pimenta-Araujo; O Burlen-Defranoux; T C Barbosa; A Cumano; A Bandeira
Journal:  J Immunol       Date:  2001-03-01       Impact factor: 5.422

Review 2.  The TCR ADAPts to integrin-mediated cell adhesion.

Authors:  Erik J Peterson
Journal:  Immunol Rev       Date:  2003-04       Impact factor: 12.988

3.  NKT cells inhibit the onset of diabetes by impairing the development of pathogenic T cells specific for pancreatic beta cells.

Authors:  Lucie Beaudoin; Véronique Laloux; Jan Novak; Bruno Lucas; Agnès Lehuen
Journal:  Immunity       Date:  2002-12       Impact factor: 31.745

Review 4.  Positive and negative selection of T cells.

Authors:  Timothy K Starr; Stephen C Jameson; Kristin A Hogquist
Journal:  Annu Rev Immunol       Date:  2002-10-16       Impact factor: 28.527

5.  Positive regulation of T cell activation and integrin adhesion by the adapter Fyb/Slap.

Authors:  E K Griffiths; C Krawczyk; Y Y Kong; M Raab; S J Hyduk; D Bouchard; V S Chan; I Kozieradzki; A J Oliveira-Dos-Santos; A Wakeham; P S Ohashi; M I Cybulsky; C E Rudd; J M Penninger
Journal:  Science       Date:  2001-09-21       Impact factor: 47.728

6.  Homeostatic expansion of T cells during immune insufficiency generates autoimmunity.

Authors:  Cecile King; Alex Ilic; Kersten Koelsch; Nora Sarvetnick
Journal:  Cell       Date:  2004-04-16       Impact factor: 41.582

7.  Acceleration of the onset of diabetes in NOD mice by thymectomy at weaning.

Authors:  M Dardenne; F Lepault; A Bendelac; J F Bach
Journal:  Eur J Immunol       Date:  1989-05       Impact factor: 5.532

8.  Paradoxical dampening of anti-islet self-reactivity but promotion of diabetes by OX40 ligand.

Authors:  Natalia Martin-Orozco; Zhibin Chen; Laurent Poirot; Elzbieta Hyatt; Andy Chen; Osami Kanagawa; Arlene Sharpe; Diane Mathis; Christophe Benoist
Journal:  J Immunol       Date:  2003-12-15       Impact factor: 5.422

9.  Unique role of CD4+CD62L+ regulatory T cells in the control of autoimmune diabetes in T cell receptor transgenic mice.

Authors:  Sylvaine You; Géraldine Slehoffer; Samia Barriot; Jean-François Bach; Lucienne Chatenoud
Journal:  Proc Natl Acad Sci U S A       Date:  2004-08-30       Impact factor: 11.205

10.  CD4+CD25+ T regulatory cells dependent on ICOS promote regulation of effector cells in the prediabetic lesion.

Authors:  Ann E Herman; Gordon J Freeman; Diane Mathis; Christophe Benoist
Journal:  J Exp Med       Date:  2004-06-07       Impact factor: 14.307

View more
  6 in total

Review 1.  Mechanisms of diabetic autoimmunity: II--Is diabetes a central or peripheral disorder of effector and regulatory cells?

Authors:  Nadir Askenasy
Journal:  Immunol Res       Date:  2016-02       Impact factor: 2.829

Review 2.  Mechanisms of diabetic autoimmunity: I--the inductive interface between islets and the immune system at onset of inflammation.

Authors:  Nadir Askenasy
Journal:  Immunol Res       Date:  2016-04       Impact factor: 2.829

3.  The adapter protein ADAP is required for selected dendritic cell functions.

Authors:  Mauro Togni; Swen Engelmann; Dirk Reinhold; Burkhart Schraven; Annegret Reinhold
Journal:  Cell Commun Signal       Date:  2012-06-06       Impact factor: 5.712

4.  The Immune Adaptor ADAP Regulates Reciprocal TGF-β1-Integrin Crosstalk to Protect from Influenza Virus Infection.

Authors:  Chunyang Li; Shaozhuo Jiao; Guojun Wang; Yunzhen Gao; Chang Liu; Xijun He; Chi Zhang; Jun Xiao; Weiyun Li; Guoquan Zhang; Bin Wei; Hualan Chen; Hongyan Wang
Journal:  PLoS Pathog       Date:  2015-04-24       Impact factor: 6.823

Review 5.  Lymphopenia, Lymphopenia-Induced Proliferation, and Autoimmunity.

Authors:  Ting-Ting Sheu; Bor-Luen Chiang
Journal:  Int J Mol Sci       Date:  2021-04-16       Impact factor: 5.923

6.  MicroRNA-146a Overexpression Impairs the Positive Selection during T Cell Development.

Authors:  Zinan Li; Siya Zhang; Ying Wan; Menghua Cai; Weiqing Wang; Yuli Zhu; Zhen Li; Yu Hu; Huaishan Wang; Hui Chen; Lianxian Cui; Xuan Zhang; Jianmin Zhang; Wei He
Journal:  Front Immunol       Date:  2018-01-23       Impact factor: 7.561

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.